Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment they have made of the report by the Commission on Human Medicines Public Assessment Report: Recommendations to support the effective and safe use of adrenaline auto-injectors, published on 11 November; and what steps they will take in response.

This report was commissioned by the Commission of Human Medicines (CHM), which is an independent advisory group to Ministers. The report and suggested actions, endorsed by the CHM, was accepted by Ministers ahead of the implementation of its recommendations.

While some recommendations have already been implemented, others are underway including changes to product labelling and improvements in adverse event reporting. Other recommendations, such as the availability of adrenaline auto-injectors, will require legislative amendment preceded by public consultation, to ensure that stakeholders are engaged and prepared before deployment.